The DOI matches its Crossref record; 142 of the 143 references it cites were found in a registry or an index, and 1 are not checked yet.
Screen, Sample, Stratify: Biomarkers and Machine Learning Compress Dementia Pathways
Open accessAbstract
Late-life cognitive complaints seldom align with a single disease entity [...]
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sex differences in pharmacokinetics and plasticity trajectories remain largely unmapped, despite evidence that network biomarkers and treatment prediction are sensitive to demographic and biological heterogeneity [93,232,233,234].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [93]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Clinical response is highly heterogeneous, and robust predictors are lacking, underscoring the need for biomarkers and stratified treatment strategies [85,91,92,93].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [93]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinson disease-associated cognitive impairment
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., & Weintraub, D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00280-3 · Cited by 1,371
Cognitive decline in Parkinson disease
Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., ffytche, D. H., Weintraub, D., & Ballard, C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.27 · Cited by 1,027
Beyond the “at risk mental state” concept: transitioning to transdiagnostic psychiatry
McGorry, P. D., Hartmann, J. A., Spooner, R., & Nelson, B. (2018) · World Psychiatry · doi:10.1002/wps.20514 · Cited by 488
Schrag, A., Siddiqui, U. F., Anastasiou, Z., Weintraub, D., & Schott, J. M. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30328-3 · Cited by 425
Tarantini, S., Tran, C. H. T., Gordon, G. R., Ungvari, Z., & Csiszar, A. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2016.11.004 · Cited by 411
Begemann, M. J., Brand, B. A., Ćurčić-Blake, B., Aleman, A., & Sommer, I. E. (2020) · Psychological Medicine · doi:10.1017/s0033291720003670 · Cited by 368
Biological aging processes underlying cognitive decline and neurodegenerative disease
Gonzales, M. M., Garbarino, V. R., Pollet, E., Palavicini, J. P., Kellogg, D. L., Kraig, E., & Orr, M. E. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158453 · Cited by 367
Antisense Oligonucleotide Therapies for Neurodegenerative Diseases
Bennett, C. F., Krainer, A. R., & Cleveland, D. W. (2019) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070918-050501 · Cited by 353
Chatterjee, P., Pedrini, S., Doecke, J. D., Thota, R., Villemagne, V. L., Doré, V., Singh, A. K., Wang, P., Rainey‐Smith, S., Fowler, C., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12724 · Cited by 312
Vascular Cognitive Impairment (VCI)
Rundek, T., Tolea, M., Ariko, T., Fagerli, E. A., & Camargo, C. J. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01170-y · Cited by 305
Research works printed but not linked: 2
- Ashton, 2022, Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease, Nat. Med., 28, 1797
- Greenwood, 2019, Endophenotypes in Schizophrenia: Digging Deeper to Identify Genetic Mechanisms, J. Psychiatry Brain Sci., 4, e190005
Cited by
Tanaka, M., Araujo, A. C., Valenti, V. E., Guiguer, E. L., Catharin, V. C. S., Gualhardi, C. M., de Souza Bastos Mazuqueli Pereira, E., de Alvares Goulart, R., de Argolo Haber, R. S., de Carvalho, A. C. A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052370 · Cited by 13
Self-citationJuhász, L., Galla, Z., Tanaka, M., & Vécsei, L. (2026) · Antioxidants · doi:10.3390/antiox15020261 · Cited by 9
Self-citationTanaka, M., & Vécsei, L. (2026) · EXCLI journal · doi:10.17179/excli2026-9522 · Cited by 3
Self-citationMechanism-First Psychobiotics: Fermented Vegetables, Dairy, and Soy for Depression and Anxiety
Tanaka, M., Detregiachi, C. R. P., Catharin, V. C. S., Pereira, E. D. S. B. M., Galhardi, C. M., Zutin, T. L. M., Hirata, M., Quesada, K. R., Catharin, V. M. C. S., Haber, R. S. D. A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146399 · Cited by 1
Self-citationSynaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Self-citation
Metadata
- Authors
- Battaglia, S., & Tanaka, M.
- Affiliations
- Università degli Studi eCampus (IT)
- University of Szeged (HU)
- Corresponding author
- Tanaka, Masaru
- Venue
- Biomedicines
- Publisher
- MDPI AG
- Published
- 2026-01-12
- Volume
- 14
- Issue
- 1
- Pages
- 159
- ISSN
- 2227-9059 (ISSN-L)
- PMC
- PMC12839027
- OpenAlex
- W7123340711
- Cited by
- 2
- References
- 135
- Citations by year
- 2026: 2
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomedicines (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- HUN-REN Hungarian Research Network funding
- #NEXTGENERATIONEU
- Ministry of University and Research
- National Recovery
- Resilience Plan
- Bial Foundation, Portugal (235/22)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- dementia, biomarkers, machine learning, cognitive complaints, late-life cognitive decline, disease heterogeneity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screen, Sample, Stratify: Biomarkers and Machine Learning Compress Dementia Pathways. https://app.cochat.ai/papers/10.3390/biomedicines14010159
- The paper
- Battaglia, S., & Tanaka, M. (2026). Screen, Sample, Stratify: Biomarkers and Machine Learning Compress Dementia Pathways. Biomedicines. https://doi.org/10.3390/biomedicines14010159
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.